awmsg logo



triamcinolone hexacetonide


Reference No. 2527

Publication date:
08/08/2017


Appraisal information

triamcinolone hexacetonide 20 mg/ml suspension for injection


Company: Intrapharm Laboratories Ltd
BNF category: Musculoskeletal and joint diseases
NMG meeting date: 07/06/2017
AWMSG meeting date: 19/07/2017
   
   
Submission Type: Limited Submission
Status: Recommended
Advice No: 1517
Ministerial ratification: 07/08/2017

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Triamcinolone hexacetonide is recommended as an option for use within NHS Wales for the treatment of juvenile idiopathic arthritis.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download